Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

75%

3 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4
3(75.0%)
N/A
1(25.0%)
4Total
Phase 4(3)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT02488460Not ApplicableCompleted

Effects of Physical Activity on Math - an RCT

Role: collaborator

NCT00162617Phase 4Unknown

The Effect of Liberal vs. Restrictive Transfusion Strategies on Rehabilitation After Hip Fracture Surgery

Role: collaborator

NCT00286936Phase 4Terminated

Incidence of Delirium in Hip Fracture Patients Randomized to Regular Hypnotics vs Placebo

Role: collaborator

NCT00162630Phase 4Completed

Fascia Iliaca Compartment Blockade as Analgesia for Hip Fractures in the Acute Phase

Role: collaborator

All 4 trials loaded